$HIMS Adds GLP-1 Injections to Weight Loss Program, Stock Surges 38%

May 20, 2024, 01:51 PM

Hims & Hers Health ($HIMS) has announced the addition of compounded GLP-1 injections to its weight loss program, a move that has significantly boosted its stock price. The telehealth company aims to offer these weight-loss shots at a discount compared to name-brands like Ozempic and Wegovy. Following the announcement, Hims & Hers' stock surged by as much as 38% in trading today, with notable increases of 10%, 20%, and 30% at various points. This strategic expansion into weight loss treatments is expected to enhance the company's market position and attract more customers seeking affordable options.